Coherus Oncology (CHRS) Proxy filing summary

Executive summary

• Annual Shareholder Meeting scheduled virtually for May 27, 2026, at 1:30 pm PST.

• Preliminary proxy filed to announce meeting and proposals; definitive proxy expected April 20, 2026.

• Shareholders will receive proxy materials and are encouraged to vote on key proposals.

Voting matters and shareholder proposals

• Proposal to reprice employee stock options with strike prices of $5 or more to the closing price on the meeting date.

• Proposal requires a majority of votes cast "FOR" to pass.

• Additional proposals may be included in the definitive proxy statement.

Board of directors and corporate governance

• Directors, executive officers, and certain employees may participate in proxy solicitation.

• Information about directors and executive officers, including their interests, is disclosed in the proxy statement.